A number of individuals had returned from a COVID-19 epidemic area in Europe or China and had fever and other symptoms compatible with respiratory infection, leading them to be considered as probable COVID-19 patients, however their NAT on nasopharyngeal samples was negative for SARS-CoV-2 as well as for other respiratory viruses tested (Table 3). Here, BRD2 is linked to respiratory tract infectious disorder.